All In MedTech

Device Trial Radar · NCT01647958

The EndoGastric Solutions TEMPO Trial

Transoral Incisionless Fundoplication (TIF) Versus Medical Proton Pump Inhibitor (PPI) Management of Refractory Gastroesophageal Reflux Disease (GERD) Symptoms

Last checked: Nov 19, 2026Latest source record: Nov 23, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

65

Actual

Start

Jun 1, 2012

Primary completion

Oct 1, 2015

Study completion Dec 1, 2017

Sponsor

Lead sponsor
EndoGastric SolutionsNot on our public-company list
Sponsor type
Industry
First posted
Jul 24, 2012

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the efficacy and safety of Transoral Incisionless Fundoplication (TIF) performed with EsophyX as compared to proton pump inhibitor (PPI) therapy for the treatment of chronic Gastroesophageal Reflux Disease (GERD) patients with refractory symptoms on Proton Pump Inhibitors (PPIs).

Conditions

  • Gastroesophageal Reflux Disease (GERD)

Interventions

  • EsophyX System with SerosaFuse fastenersDevice

    Transoral Incisionless Fundoplication (TIF)/Transoral incisionless esophago-gastric fundoplication using the EsophyX System with SerosaFuse fasteners

  • PPIDrug

    Control Arm participants will take maximum standard dose of PPI during Initial Study period

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Reporting GERD (Gastroesophageal Reflux Disease) Symptom Elimination or Clinically Significant Improvement Evaluated by RSI (Reflux Symptom Index) and RDQ (Reflux Disease Questionnaire).Time frame: 6 months
  2. Number of Participants Reporting Elimination of Daily Troublesome Regurgitation Using a Validated Questionnaire for AssessmentTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • EndoGastric Solutions

    Redmond, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.